Yoshifumi Tachibana
Login to view DISC.Yoshifumi Tachibana is the Head of Experimental Medicine Inflammation at Boehringer Ingelheim Japan. With a PhD from Kitasato University and a Project Management Professional (PMP) certification, he specializes in global clinical development and operations, particularly in oncology and inflammation.
He has published extensive research on the subject of "drug lag"—the delay in new drug availability in Japan compared to the U. S. —and is focused on enhancing the accessibility of novel medicines for patients.
Read the full overview →How Yoshifumi shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics Yoshifumi cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Other Boehringer Ingelheim Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.